Raymond James Trust N.A. Takeda Pharmaceutical CO LTD Transaction History

Raymond James Trust N.A.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 18, 2021	SELL	$16.3 - $17.26 $187,857 - $198,921	-11,525 Closed	0 $0
Q2 2021 Jul 20, 2021	BUY	$16.55 - $18.64 $148 - $167	9 Added 0.08%	11,525 $194,000
Q1 2021 May 03, 2021	SELL	$16.71 - $19.9 $212,718 - $253,326	-12,730 Reduced 52.5%	11,516 $211,000
Q4 2020 Jan 13, 2021	SELL	$15.39 - $18.97 $9,495 - $11,704	-617 Reduced 2.48%	24,246 $442,000
Q3 2020 Oct 14, 2020	BUY	$17.1 - $19.19 $26,812 - $30,089	1,568 Added 6.73%	24,863 $444,000
Q2 2020 Jul 16, 2020	SELL	$14.59 - $19.5 $5,325 - $7,117	-365 Reduced 1.54%	23,295 $417,000
Q1 2020 Apr 17, 2020	BUY	$13.02 - $20.31 $44,372 - $69,216	3,408 Added 16.83%	23,660 $359,000
Q4 2019 Jan 14, 2020	BUY	$16.88 - $20.83 $16,981 - $20,954	1,006 Added 5.23%	20,252 $399,000
Q3 2019 Oct 24, 2019	BUY	$16.15 - $17.99 $82,461 - $91,856	5,106 Added 36.11%	19,246 $331,000
Q2 2019 Jul 15, 2019	BUY	$16.58 - $20.49 $53,271 - $65,834	3,213 Added 29.4%	14,140 $251,000
Q1 2019 Apr 15, 2019	BUY	$16.7 - $21.52 $182,480 - $235,149	10,927 New	10,927 $222,000

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

Stay updated on Raymond James Trust N.A. with notifications on news.